| (-)-BO 2367 |
|
|
|
|
|
| (-)-Eleutherin |
|
|
|
|
|
| (1-OH)-Exatecan |
|
|
|
|
|
| (1R,2S,7R)-Sitafloxacin |
|
|
|
|
|
| (1R,9R)-Exatecan mesylate |
|
|
|
|
99.49% |
| (1R,9S)-Exatecan |
|
|
|
|
|
| (1S,2R,7S)-Sitafloxacin |
|
|
|
|
|
| (1S,9R)-Exatecan mesylate |
|
|
|
|
99.11% |
| (4-NH2)-Exatecan |
|
|
|
|
99.93% |
| (4-NH2)-Exatecan-d5 |
|
|
|
|
98.62% |
| (5-Cl)-Exatecan |
|
|
|
|
|
| (5-Cl)-Exatecan TFA |
|
|
|
|
|
| (9R)-Exatecan |
|
|
|
|
|
| (R)-(4-NH2)-Exatecan |
|
|
|
|
|
| (R)-Amrubicin |
|
|
|
|
|
| (R)-Camptothecin |
|
|
|
|
|
| (R)-Exatecan Intermediate 1 |
|
|
|
|
|
| (Rac)-7-Ethyl-10-hydroxycamptothecin |
|
|
|
|
|
| (Rac)-Besifloxacin hydrochloride |
|
|
|
|
|
| (S)-10-Hydroxycamptothecin-d5 |
|
|
|
|
|
| (S)-Benzyl 2-cyclopropyl-2-hydroxyacetate |
|
|
|
|
|
| (S)-Gyramide A |
|
|
|
|
|
| (±)-10-Hydroxycamptothecin |
|
|
|
|
99.57% |
| (±)-E-Homocamptothecin |
|
|
|
|
|
| (±)-Evodiamine |
|
|
|
|
99.74% |
| (αR)-Cyclopropaneacetamide-Exatecan |
|
|
|
|
99.93% |
| 1,4-Di-tert-butylbenzene |
|
|
|
|
|
| 10-Boc-SN-38 |
|
|
|
|
|
| 10-Nitrocamptothecin |
|
|
|
|
|
| 10NH2-11F-Camptothecin |
|
|
|
|
|
| 10NH2-11F-Camptothecin TFA |
|
|
|
|
|
| 11-Desethyl Irinotecan |
|
|
|
|
97.0% |
| 2-MSP(4-OMe)-5-HA-PEG8-VA-Exatecan |
|
|
|
|
|
| 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-Exatecan |
|
|
|
|
98.10% |
| 2-MSP-5-HA-VA-PAB-Exatecan |
|
|
|
|
97.96% |
| 2-Methoxycinnamaldehyde |
|
|
|
|
98.0% |
| 20-O-Acetylcamptothecin |
|
|
|
|
98.0% |
| 3,6-Diamino-9(10H)-acridone |
|
|
|
|
|
| 3-Fluoro-evodiamine glucose |
|
|
|
|
|
| 4"-Isovalerylspiramycin I |
|
|
|
|
|
| (rac)-Exatecan Intermediate 1 |
|
|
|
|
99.97% |
| 7-Methoxy-9-methylfuro[2,3-b]-quinoline-4,5,8(9H)-trione |
|
|
|
|
|
| 7-Ethylcamptothecin |
|
|
|
|
99.58% |
| 7Ethanol-10NH2-11F-Camptothecin |
|
|
|
|
|
| 8-Chloro-ATP |
|
|
|
|
|
| 8-Chloro-ATP tetrasodium |
|
|
|
|
|
| 9-Chloromethyl-10-hydroxy-11-F-Camptothecin |
|
|
|
|
|
| 9-Hydroxyellipticin |
|
|
|
|
|
| 9-Hydroxyellipticine hydrochloride |
|
|
|
|
99.0% |
| 9-Methoxycamptothecin |
|
|
|
|
99.13% |
| 9-Aminocamptothecin |
|
|
|
|
98.80% |
| A 9387 |
|
|
|
|
|
| A-74932 hydrochloride |
|
|
|
|
|
| A1062 |
|
|
|
|
|
| A20832 |
|
|
|
|
|
| ABBV-706 |
|
|
|
|
99.71% |
| Ac-Exatecan |
|
|
|
|
99.02% |
| Ac-Exatecan-d5 |
|
|
|
|
99.93% |
| ACT-387042 |
|
|
|
|
|
| ADC Control Human IgG1-Deruxtecan (DAR 4) |
|
|
|
|
95.61% |
| ADC Control Human IgG1-Deruxtecan (DAR 8) |
|
|
|
|
99.32% |
| Albaconol |
|
|
|
|
|
| Albicidin |
|
|
|
|
|
| Aldoxorubicin |
|
|
|
|
95.56% |
| Aldoxorubicin hydrochloride |
|
|
|
|
|
| Alloc-DOX |
|
|
|
|
98.40% |
| Aminocaproyl-Val-Cit-PABC-Exatecan |
|
|
|
|
|
| Aminocaproyl-Val-Cit-PABC-Exatecan TFA |
|
|
|
|
99.18% |
| Amonafide dihydrochloride |
|
|
|
|
|
| Amonafide L-malate |
|
|
|
|
|
| Amsacrine (gluconate) |
|
|
|
|
|
| Amsacrine isethionate |
|
|
|
|
|
| Amsacrine lactate |
|
|
|
|
|
| AMT-562 |
|
|
|
|
|
| Anti-CCL2 (Carlumab)-MC-Vc-PAB-SN38 |
|
|
|
|
|
| Anti-MRSA agent 7 |
|
|
|
|
|
| Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 |
|
|
|
|
|
| Anti-Trypanosoma cruzi agent-9 |
|
|
|
|
|
| Antibacterial agent 187 |
|
|
|
|
|
| Antibacterial agent 229 |
|
|
|
|
|
| Antibacterial agent 236 |
|
|
|
|
|
| Antibacterial agent 327 |
|
|
|
|
|
| Antibacterial agent 352 |
|
|
|
|
|
| Anticancer agent 214 |
|
|
|
|
|
| Anticancer agent 215 |
|
|
|
|
|
| Anticancer agent 216 |
|
|
|
|
|
| Anticancer agent 217 |
|
|
|
|
|
| Anticancer agent 218 |
|
|
|
|
|
| Anticancer agent 219 |
|
|
|
|
|
| Anticancer agent 276 |
|
|
|
|
|
| Anticancer agent 75 |
|
|
|
|
|
| Anticancer agent 76 |
|
|
|
|
|
| Antitumor agent-102 |
|
|
|
|
|
| Antitumor agent-203 |
|
|
|
|
99.07% |
| Antitumor agent-63 |
|
|
|
|
|
| Apoptosis inducer 54 |
|
|
|
|
|
| AQ4 |
|
|
|
|
97.34% |
| ARN-21934 |
|
|
|
|
98.02% |
| ARN21929 |
|
|
|
|
99.63% |
| ARN24139 |
|
|
|
|
|
| Asulacrine isethionate |
|
|
|
|
|
| AT-9 |
|
|
|
|
|
| Atiratecan |
|
|
|
|
|
| AuL1 |
|
|
|
|
|
| AuM1Gly |
|
|
|
|
|
| AuM1Phe |
|
|
|
|
|
| AV-DL055 |
|
|
|
|
|
| AZ14170133 |
|
|
|
|
99.73% |
| AZ14170133-d5 |
|
|
|
|
|
| AZD0516 |
|
|
|
|
99.15% |
| AZD5099 |
|
|
|
|
98.40% |
| Azithromycin-amide-C3-amide-quinoxaline |
|
|
|
|
|
| Bakuchicin |
|
|
|
|
|
| Banoxantrone dihydrochloride |
|
|
|
|
99.43% |
| Banoxantrone-d12 |
|
|
|
|
|
| Banoxantrone-d12 dihydrochloride |
|
|
|
|
95.03% |
| Batracylin |
|
|
|
|
|
| BCPT02 |
|
|
|
|
99.70% |
| BE-10988 |
|
|
|
|
|
| Becatecarin |
|
|
|
|
|
| Bethoxazin |
|
|
|
|
98.45% |
| Bimolane |
|
|
|
|
|
| Biotin-doxorubicin |
|
|
|
|
|
| Bisantrene dihydrochloride |
|
|
|
|
98.85% |
| BMS-250749 |
|
|
|
|
|
| BNS-22 |
|
|
|
|
99.50% |
| Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT |
|
|
|
|
98.65% |
| BWC0977 |
|
|
|
|
|
| BWC0977 formic |
|
|
|
|
99.61% |
| C-1311 |
|
|
|
|
|
| Camptothecin analog-1 |
|
|
|
|
|
| Camptothecin-20(S)-O-propionate |
|
|
|
|
99.60% |
| Camptothecin-20(S)-O-propionate hydrate |
|
|
|
|
|
| Camsirubicin |
|
|
|
|
|
| CB07-Exatecan |
|
|
|
|
98.97% |
| CH-0793076 |
|
|
|
|
|
| CH-0793076 TFA |
|
|
|
|
98.71% |
| Chimmitecan |
|
|
|
|
98.96% |
| Chloroquinoxaline sulfonamide |
|
|
|
|
99.06% |
| Cholesterol hemisuccinate Tris salt |
|
|
|
|
99.98% |
| Ciprofloxacin |
|
|
|
|
|
| Ciprofloxacin-13C3,15N monohydrochloride |
|
|
|
|
99.9% |
| cis-THSG |
|
|
|
|
|
| CL2-MMT-SN38 |
|
|
|
|
|
| Coralyne chloride |
|
|
|
|
98.39% |
| CP-67015 |
|
|
|
|
|
| CP-67804 |
|
|
|
|
|
| CP-84364 |
|
|
|
|
|
| CPT-Se3 |
|
|
|
|
|
| CPT-Se4 |
|
|
|
|
|
| Cryptolepine |
|
|
|
|
|
| CS1 |
|
|
|
|
|
| Cu(II)-Elesclomol |
|
|
|
|
99.88% |
| Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan |
|
|
|
|
97.31% |
| Cyclopropaneacetamide-Exatecan |
|
|
|
|
99.60% |
| DACA |
|
|
|
|
98.89% |
| Datopotamab deruxtecan (solution) |
|
|
|
|
99.98% |
| Daun02 |
|
|
|
|
98.72% |
| Daunorubicin-13C,d3 |
|
|
|
|
|
| DBCO-PEG3-GGFG-Exatecan |
|
|
|
|
95.65% |
| DBCO-PEG3-VC-Exatecan |
|
|
|
|
96.70% |
| DBCO-PEG8-VKG-CPT2 |
|
|
|
|
|
| DBCO-β-Glu-PEG12-Exatecan |
|
|
|
|
98.63% |
| Decyclohexanamine-Exatecan |
|
|
|
|
98.38% |
| Deoxynybomycin |
|
|
|
|
|
| Deruxtecan-Eribulin |
|
|
|
|
95.83% |
| Dichlorogelignate |
|
|
|
|
|
| Diflomotecan |
|
|
|
|
|
| DiPT-4 |
|
|
|
|
|
| DK 507k |
|
|
|
|
|
| DNA Gyrase-IN-18 |
|
|
|
|
|
| DNA Gyrase-IN-6 |
|
|
|
|
|
| DNA gyrase/Topo IV-IN-1 |
|
|
|
|
|
| DNA gyrase/Topo IV-IN-2 |
|
|
|
|
|
| DNA gyrase/Topo IV-IN-3 |
|
|
|
|
|
| DNA topoisomerase II inhibitor 1 |
|
|
|
|
|
| DNA/TOP2A-IN-1 |
|
|
|
|
|
| Dox-btn2 |
|
|
|
|
98.80% |
| Doxorubicin liposome |
|
|
|
|
|
| DRF-1042 |
|
|
|
|
98.33% |
| DS-3939a |
|
|
|
|
99.15% |
| DS21412020 |
|
|
|
|
|
| DTS-108 |
|
|
|
|
|
| DXd |
|
|
|
|
99.30% |
| DXd-d5 |
|
|
|
|
99.57% |
| Echinoside A |
|
|
|
|
|
| Edotecarin |
|
|
|
|
|
| EGFR-IN-116 |
|
|
|
|
|
| EGFR-IN-45 |
|
|
|
|
|
| EGFR-IN-57 |
|
|
|
|
|
| EGFR/VEGFR2-IN-13 |
|
|
|
|
|
| EIDD 1931-13C,15N2 |
|
|
|
|
|
| EIDD-1931 |
|
|
|
|
99.98% |
| EIDD-1931-d2 |
|
|
|
|
|
| Eleutherin |
|
|
|
|
99.22% |
| Elfetabart drozuntecan |
|
|
|
|
|
| Elinafide |
|
|
|
|
98.02% |
| Elomotecan |
|
|
|
|
|
| Elomotecan hydrochloride |
|
|
|
|
|
| Elomotecan TFA |
|
|
|
|
|
| Emodin-8-glucoside |
|
|
|
|
99.35% |
| erythro-Austrobailignan-6 |
|
|
|
|
|
| Ethonafide |
|
|
|
|
|
| Etoposide phosphate disodium |
|
|
|
|
|
| Eupolauridine |
|
|
|
|
|
| Exatecan analog 13 |
|
|
|
|
|
| Exatecan analog 36 |
|
|
|
|
98.71% |
| Exatecan analog 38 |
|
|
|
|
|
| Exatecan analogue 1 |
|
|
|
|
|
| Exatecan hydrochloride |
|
|
|
|
|
| Exatecan Intermediate 1-d2 |
|
|
|
|
|
| Exatecan intermediate 10 |
|
|
|
|
99.91% |
| Exatecan intermediate 11 |
|
|
|
|
|
| Exatecan Intermediate 3 |
|
|
|
|
99.83% |
| Exatecan Intermediate 7 |
|
|
|
|
|
| Exatecan intermediate 8 |
|
|
|
|
|
| Exatecan intermediate 9 |
|
|
|
|
|
| Exatecan mesylate |
|
|
|
|
|
| Exatecan-amide-bicyclo[1.1.1]pentan-1-ol |
|
|
|
|
|
| Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol |
|
|
|
|
|
| Exatecan-amide-CH2-O-CH2-CH2-OH |
|
|
|
|
|
| Exatecan-amide-cyclopropanol |
|
|
|
|
98.57% |
| Exatecan-methylacetamide-OH |
|
|
|
|
97.30% |
| F-14512 |
|
|
|
|
98.04% |
| F-14512 hydrochloride |
|
|
|
|
|
| Fagopyrine |
|
|
|
|
|
| FLT3-IN-13 |
|
|
|
|
|
| Fmoc-leucine-15N |
|
|
|
|
98.5% |
| Fmoc-Val-Cit-PAB-Exatecan |
|
|
|
|
|
| Fostriecin |
|
|
|
|
|
| FZ-AD005 |
|
|
|
|
97.04% |
| Galarubicin hydrochloride |
|
|
|
|
|
| Garenoxacin mesylate |
|
|
|
|
|
| Gatifloxacin sesquihydrate |
|
|
|
|
|
| GC-072 |
|
|
|
|
|
| GENA-104A16 |
|
|
|
|
|
| Genz-644282 |
|
|
|
|
99.13% |
| Gepotidacin |
|
|
|
|
99.92% |
| Gepotidacin hydrochloride |
|
|
|
|
|
| Gepotidacin mesylate hydrate |
|
|
|
|
99.62% |
| GGFG-amide-glycol-amide-Exatecan |
|
|
|
|
95.74% |
| GGFG-PAB-Exatecan |
|
|
|
|
99.71% |
| GGFG-PAB-Exatecan TFA |
|
|
|
|
|
| GI-149893 |
|
|
|
|
|
| Gly-7-MAD-MDCPT |
|
|
|
|
|
| Gly-7-MAD-MDCPT hydrochloride |
|
|
|
|
98.27% |
| Gly-7-MAD-MDCPT TFA |
|
|
|
|
|
| Gly-Cyclopropane-Exatecan |
|
|
|
|
|
| Gly-Gly-Phe-Gly-NH-O-CO-Exatecan hydrochloride |
|
|
|
|
99.52% |
| Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide |
|
|
|
|
99.01% |
| Gly-Mal-Gly-Gly-Phe-Gly-amide-methylcyclopropane-Exatecan |
|
|
|
|
|
| Glycyl-Exatecan-d5 hydrochloride |
|
|
|
|
98.97% |
| GSK945237 |
|
|
|
|
|
| Guajadial C |
|
|
|
|
|
| HDAC/Top-IN-1 |
|
|
|
|
|
| Heliquinomycin |
|
|
|
|
|
| HSP90-IN-13 |
|
|
|
|
|
| Hsp90-IN-48 |
|
|
|
|
|
| HU 331 |
|
|
|
|
|
| Huanglongmycin N |
|
|
|
|
|
| Hydroxyrubicin |
|
|
|
|
|
| Icariside E3 |
|
|
|
|
|
| ICRF-193 |
|
|
|
|
99.64% |
| ICRF-196 |
|
|
|
|
|
| Idarubicin |
|
|
|
|
99.89% |
| Ifinatamab deruxtecan |
|
|
|
|
98.98% |
| IID432 |
|
|
|
|
|
| IKE16 |
|
|
|
|
|
| IKKβ-IN-6 |
|
|
|
|
|
| Indimitecan |
|
|
|
|
98.30% |
| Indimitecan hydrochloride |
|
|
|
|
|
| Indotecan |
|
|
|
|
98.0% |
| Indotecan hydrochloride |
|
|
|
|
99.80% |
| iNOS/TopoI-IN-1 |
|
|
|
|
|
| Intoplicine dimesylate |
|
|
|
|
98.28% |
| iRGD-CPT |
|
|
|
|
|
| Irinotecan liposome |
|
|
|
|
|
| Karenitecin |
|
|
|
|
98.02% |
| KT32 |
|
|
|
|
|
| KW-2170 hydrochloride |
|
|
|
|
|
| LD-38 |
|
|
|
|
|
| LD2-3 |
|
|
|
|
|
| Levofloxacin sodium |
|
|
|
|
|
| LMP517 |
|
|
|
|
99.58% |
| LMP744 |
|
|
|
|
98.33% |
| LMP744 hydrochloride |
|
|
|
|
99.08% |
| Lss-11 |
|
|
|
|
|
| Luotonin A |
|
|
|
|
99.81% |
| Luotonin F |
|
|
|
|
|
| Lurtotecan |
|
|
|
|
|
| Lurtotecan dihydrochloride |
|
|
|
|
98.95% |
| M3554 |
|
|
|
|
98.74% |
| Makaluvamine A |
|
|
|
|
|
| Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB-Exatecan |
|
|
|
|
99.95% |
| Mal-cyclohexane-Gly-Gly-Phe-Gly-Exatecan |
|
|
|
|
|
| Mal-Exatecan |
|
|
|
|
99.39% |
| Mal-Gly-PAB-Exatecan-D-glucuronic acid |
|
|
|
|
99.82% |
| Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan |
|
|
|
|
98.62% |
| Mal-PEG8-Phe-Lys-PAB-Exatecan |
|
|
|
|
|
| Mal-PEG8-Phe-Lys-PAB-Exatecan TFA |
|
|
|
|
98.66% |
| Mal-PEG8-Val-Ala-PAB-Exatecan |
|
|
|
|
99.48% |
| Mal-VC-PAB-DMEA-PNU-159682 |
|
|
|
|
99.36% |
| Maleimide-Ph(3,5-F)-PEG4-Val-Ala-MF-6 |
|
|
|
|
|
| Mauritianin |
|
|
|
|
99.83% |
| MC-DOXHZN |
|
|
|
|
|
| MC-DOXHZN hydrochloride |
|
|
|
|
98.0% |
| MC-GGFG-AM-(10Me-11F-Camptothecin) |
|
|
|
|
98.99% |
| MC-GGFG-AM-(10Me-11F-Camptothecin) intermediate-1 |
|
|
|
|
97.47% |
| MC-GGFG-Exatecan |
|
|
|
|
96.47% |
| MC-GGFG-PAB-Exatecan |
|
|
|
|
99.31% |
| MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan |
|
|
|
|
97.37% |
| MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan |
|
|
|
|
98.99% |
| MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan |
|
|
|
|
99.16% |
| MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan |
|
|
|
|
99.55% |
| MC-Gly-Gly-Phe-Gly-GABA-Exatecan |
|
|
|
|
99.72% |
| Mc-Lys(PEG12)-Cap-Ala-Ala-PABC-exatecan |
|
|
|
|
|
| Mc-PEG4-Val-Ala-PAB-Exatecan |
|
|
|
|
99.65% |
| MC-VA-PAB-Exatecan |
|
|
|
|
98.88% |
| MC-Val-Cit-Gly-exatecan-β-D-glucopyranosiduronic acid |
|
|
|
|
|
| MC-Val-Cit-PAB-Exatecan |
|
|
|
|
99.57% |
| MDM2-IN-27 |
|
|
|
|
|
| Melicopidine |
|
|
|
|
|
| Merbarone |
|
|
|
|
99.0% |
| meso-Tetra(4-pyridyl)porphine |
|
|
|
|
≥95.0% |
| MGB1Y |
|
|
|
|
|
| MGB4 |
|
|
|
|
|
| Mitoxantrone diacetate |
|
|
|
|
|
| Mitoxantrone hydrochloride liposome |
|
|
|
|
|
| Mitoxantrone-d8 hydrochloride |
|
|
|
|
|
| MN33-47 |
|
|
|
|
|
| MN33-63 |
|
|
|
|
|
| Moflomycin |
|
|
|
|
|
| MSN8C |
|
|
|
|
|
| Murrayanol |
|
|
|
|
|
| Exatecan Intermediate 5 |
|
|
|
|
99.90% |
| N,N-Dimethyldoxorubicin |
|
|
|
|
|
| Exatecan Intermediate 6 |
|
|
|
|
99.45% |
| N-(Amino-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(Azido-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(Azido-PEG4)-N-(PEG4-Val-Cit-PAB-MMAF)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(DBCO-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(endo-BCN-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(Mal)-N-(PEG8-Val-Cit-PAB-MMAE)-N-(PEG8-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(Mal-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(Mal-PEG4)-N-(PEG4-Val-Cit-PAB-MMAF)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(NHS-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(NHS-PEG4)-N-(PEG4-Val-Cit-PAB-MMAF)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| N-(TCO-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) |
|
|
|
|
|
| Namitecan |
|
|
|
|
98.03% |
| NBTI 5463 |
|
|
|
|
|
| NBTIs-IN-6 |
|
|
|
|
|
| NBTIs-IN-7 |
|
|
|
|
|
| Nectandrin B |
|
|
|
|
|
| NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT |
|
|
|
|
98.71% |
| NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT hydrochloride |
|
|
|
|
98.46% |
| NH2-methylpropanamide-Exatecan TFA |
|
|
|
|
|
| NHC-diphosphate |
|
|
|
|
98.80% |
| NHC-diphosphate triammonium |
|
|
|
|
98.80% |
| NHC-triphosphate |
|
|
|
|
|
| NHC-triphosphate tetraammonium |
|
|
|
|
97.09% |
| NHC-triphosphate tetrasodium |
|
|
|
|
|
| Nidulalin A |
|
|
|
|
|
| Niranthin |
|
|
|
|
|
| NISC-6 |
|
|
|
|
|
| NK 314 |
|
|
|
|
|
| NK-611 |
|
|
|
|
|
| NL-26 |
|
|
|
|
|
| NSC 660028 |
|
|
|
|
|
| NSC 727357 |
|
|
|
|
|
| NU/ICRF 500 |
|
|
|
|
|
| Orenasitecan |
|
|
|
|
|
| OSu-Val-Cit-PAB-Exa |
|
|
|
|
|
| OSUAB-0284 |
|
|
|
|
|
| P5(PEG12)-VC-PAB-Exatecan |
|
|
|
|
|
| P5(PEG24)-VC-PAB-Exatecan |
|
|
|
|
|
| Pazelliptine |
|
|
|
|
|
| PBX-7016 |
|
|
|
|
|
| PD 0305970 |
|
|
|
|
|
| PD 124816 |
|
|
|
|
|
| Pericosine A |
|
|
|
|
|
| Phenoxodiol |
|
|
|
|
99.89% |
| Piroxantrone |
|
|
|
|
|
| PluriSIn #2 |
|
|
|
|
98.0% |
| PNU-142586 |
|
|
|
|
|
| PNU-142586 sodium |
|
|
|
|
|
| PNU-159682 |
|
|
|
|
98.58% |
| PNU-159682 |
|
|
|
|
|
| Precemtabart tocentecan |
|
|
|
|
99.31% |
| Premafloxacin |
|
|
|
|
|
| Proscillaridin A |
|
|
|
|
99.0% |
| Puxitatug samrotecan |
|
|
|
|
98.51% |
| Puxitatug samrotecan drug-linker |
|
|
|
|
98.98% |
| PY-4Car2 |
|
|
|
|
|
| Pyrazoloacridine |
|
|
|
|
98.05% |
| Q901 |
|
|
|
|
|
| Q901 TFA |
|
|
|
|
|
| QHL-1618 |
|
|
|
|
|
| Quercetin-3'-O-glucoside |
|
|
|
|
98.48% |
| Razoxane |
|
|
|
|
99.78% |
| Rebeccamycin |
|
|
|
|
|
| Retelliptine |
|
|
|
|
|
| Rezetecan |
|
|
|
|
99.60% |
| Ro 47-3359 |
|
|
|
|
|
| RPR121056 |
|
|
|
|
99.88% |
| RPR121056-d3 |
|
|
|
|
|
| RPR132595A-d3 |
|
|
|
|
|
| RSK2/TOP2-IN-1 |
|
|
|
|
|
| Rubitecan |
|
|
|
|
99.41% |
| S 39625 |
|
|
|
|
|
| Sabarubicin |
|
|
|
|
|
| Saintopin |
|
|
|
|
|
| Salvicine |
|
|
|
|
|
| SDOX |
|
|
|
|
|
| Seconeolitsine |
|
|
|
|
98.65% |
| SelB-1 |
|
|
|
|
|
| SeSA-HCPT |
|
|
|
|
|
| Silatecan |
|
|
|
|
96.62% |
| Simmitecan hydrochloride |
|
|
|
|
|
| SN-28049 |
|
|
|
|
|
| SN-38 |
|
|
|
|
99.94% |
| SN-38-13C6 |
|
|
|
|
|
| SN-38-CM2 |
|
|
|
|
|
| SN-38-d3 |
|
|
|
|
98.79% |
| SN-398 |
|
|
|
|
|
| Sobuzoxane |
|
|
|
|
98.05% |
| SPR719 |
|
|
|
|
99.39% |
| SQDG |
|
|
|
|
99.0% |
| Suptopin-2 |
|
|
|
|
|
| SW044248 |
|
|
|
|
98.92% |
| T-2513 |
|
|
|
|
|
| T-2513 hydrochloride |
|
|
|
|
|
| T638 |
|
|
|
|
98.61% |
| Tafluposide |
|
|
|
|
|
| Tapcin |
|
|
|
|
|
| TAS-103 |
|
|
|
|
99.69% |
| TAS-103 dihydrochloride |
|
|
|
|
98.45% |
| Telisotuzumab Adizutecan |
|
|
|
|
|
| Tenifatecan |
|
|
|
|
99.78% |
| TGA-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT |
|
|
|
|
|
| TH1338 |
|
|
|
|
98.77% |
| Thaspine acetate |
|
|
|
|
|
| Tilatamig samrotecan |
|
|
|
|
95.26% |
| Tizetatug rezetecan |
|
|
|
|
≥99.0% |
| TLC388 |
|
|
|
|
|
| Top/HDAC-IN-1 |
|
|
|
|
|
| Top/HDAC-IN-2 |
|
|
|
|
|
| Top/HDAC-IN-3 |
|
|
|
|
|
| TOP1 Human Pre-designed siRNA Set A |
|
|
|
|
|
| Top1 inhibitor 1 |
|
|
|
|
99.67% |
| Top1 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
| Top1 Rat Pre-designed siRNA Set A |
|
|
|
|
|
| Top1-IN-2 |
|
|
|
|
|
| Top1/2-IN-1 |
|
|
|
|
|
| TOP1/TDP1-IN-1 |
|
|
|
|
|
| TOP3B-IN-1 |
|
|
|
|
|
| TopBP1-IN-1 |
|
|
|
|
98.35% |
| Topi MF-6 |
|
|
|
|
99.79% |
| Topo I-IN-1 |
|
|
|
|
|
| Topo I/COX-2-IN-1 |
|
|
|
|
|
| Topo I/COX-2-IN-2 |
|
|
|
|
|
| Topo I/DDX5-IN-1 |
|
|
|
|
|
| Topo I/II-IN-1 |
|
|
|
|
|
| Topo I/II-IN-2 |
|
|
|
|
|
| Topo I/II-IN-3 |
|
|
|
|
|
| Topo II/HDAC-IN-1 |
|
|
|
|
|
| Topo II/HDAC-IN-2 |
|
|
|
|
|
| Topobexin |
|
|
|
|
99.04% |
| TOPOI/PARP-1-IN-1 |
|
|
|
|
|
| TOPOI/PARP-1-IN-2 |
|
|
|
|
|
| TopoII/tubulin-IN-1 |
|
|
|
|
|
| Topoisomerase I inhibitor 10 |
|
|
|
|
|
| Topoisomerase I inhibitor 11 |
|
|
|
|
|
| Topoisomerase I inhibitor 12 |
|
|
|
|
|
| Topoisomerase I inhibitor 13 |
|
|
|
|
|
| Topoisomerase I inhibitor 14 |
|
|
|
|
|
| Topoisomerase I inhibitor 15 |
|
|
|
|
|
| Topoisomerase I inhibitor 16 |
|
|
|
|
|
| Topoisomerase I inhibitor 17 |
|
|
|
|
|
| Topoisomerase I inhibitor 2 |
|
|
|
|
|
| Topoisomerase I inhibitor 3 |
|
|
|
|
|
| Topoisomerase I inhibitor 4 |
|
|
|
|
|
| Topoisomerase I inhibitor 5 |
|
|
|
|
|
| Topoisomerase I inhibitor 6 |
|
|
|
|
|
| Topoisomerase I inhibitor 7 |
|
|
|
|
|
| Topoisomerase I inhibitor 8 |
|
|
|
|
99.87% |
| Topoisomerase I inhibitor 9 |
|
|
|
|
|
| Topoisomerase I-IN-18 |
|
|
|
|
|
| Topoisomerase I-IN-19 |
|
|
|
|
|
| Topoisomerase I-IN-20 |
|
|
|
|
|
| Topoisomerase I-IN-21 |
|
|
|
|
|
| Topoisomerase I-IN-22 |
|
|
|
|
|
| Topoisomerase I/II inhibitor 2 |
|
|
|
|
|
| Topoisomerase I/II inhibitor 3 |
|
|
|
|
|
| Topoisomerase I/II inhibitor 4 |
|
|
|
|
|
| Topoisomerase I/II inhibitor 5 |
|
|
|
|
|
| Topoisomerase I/II inhibitor 6 |
|
|
|
|
|
| Topoisomerase I/II inhibitor 7 |
|
|
|
|
|
| Topoisomerase I/II inhibitor 8 |
|
|
|
|
|
| Topoisomerase I/II-IN-1 |
|
|
|
|
|
| Topoisomerase I/II-IN-9 |
|
|
|
|
|
| Topoisomerase I/IIα-IN-1 |
|
|
|
|
|
| Topoisomerase II inhibitor 1 |
|
|
|
|
99.9% |
| Topoisomerase II inhibitor 10 |
|
|
|
|
|
| Topoisomerase II inhibitor 11 |
|
|
|
|
|
| Topoisomerase II inhibitor 12 |
|
|
|
|
|
| Topoisomerase II inhibitor 13 |
|
|
|
|
98.07% |
| Topoisomerase II inhibitor 14 |
|
|
|
|
99.68% |
| Topoisomerase II inhibitor 15 |
|
|
|
|
|
| Topoisomerase II inhibitor 16 |
|
|
|
|
|
| Topoisomerase II inhibitor 17 |
|
|
|
|
|
| Topoisomerase II inhibitor 18 |
|
|
|
|
|
| Topoisomerase II inhibitor 19 |
|
|
|
|
|
| Topoisomerase II inhibitor 20 |
|
|
|
|
98.44% |
| Topoisomerase II inhibitor 20 TFA |
|
|
|
|
|
| Topoisomerase II inhibitor 23 |
|
|
|
|
|
| Topoisomerase II inhibitor 3 |
|
|
|
|
|
| Topoisomerase II inhibitor 4 |
|
|
|
|
|
| Topoisomerase II inhibitor 5 |
|
|
|
|
|
| Topoisomerase II inhibitor 6 |
|
|
|
|
|
| Topoisomerase II inhibitor 7 |
|
|
|
|
|
| Topoisomerase II inhibitor 8 |
|
|
|
|
|
| Topoisomerase II inhibitor 9 |
|
|
|
|
|
| Topoisomerase II α, Human |
|
|
|
|
|
| Topoisomerase II β, Human |
|
|
|
|
|
| Topoisomerase II, Yeast |
|
|
|
|
|
| Topoisomerase II-IN-24 |
|
|
|
|
|
| Topoisomerase II-IN-25 |
|
|
|
|
|
| Topoisomerase II-IN-26 |
|
|
|
|
|
| Topoisomerase II/EGFR-IN-1 |
|
|
|
|
|
| Topoisomerase II/EGFR-IN-2 |
|
|
|
|
|
| Topoisomerase IIα-IN-1 |
|
|
|
|
|
| Topoisomerase IIα-IN-10 |
|
|
|
|
|
| Topoisomerase IIα-IN-11 |
|
|
|
|
|
| Topoisomerase IIα-IN-2 |
|
|
|
|
|
| Topoisomerase IIα-IN-3 |
|
|
|
|
|
| Topoisomerase IIα-IN-4 |
|
|
|
|
|
| Topoisomerase IIα-IN-5 |
|
|
|
|
|
| Topoisomerase IIα-IN-6 |
|
|
|
|
|
| Topoisomerase IIα-IN-7 |
|
|
|
|
|
| Topoisomerase IIα-IN-8 |
|
|
|
|
|
| Topoisomerase IIα-IN-9 |
|
|
|
|
|
| Topoisomerase inhibitor 2 |
|
|
|
|
|
| Topoisomerase inhibitor 3 |
|
|
|
|
|
| Topoisomerase inhibitor 4 |
|
|
|
|
|
| Topoisomerase inhibitor 5 |
|
|
|
|
|
| Topoisomerase inhibitor 6 |
|
|
|
|
|
| Topoisomerase IV inhibitor 1 |
|
|
|
|
|
| Topoisomerase IV inhibitor 2 |
|
|
|
|
|
| Topoisomerase IV, Acinetobacter baumannii |
|
|
|
|
|
| Topoisomerase IV, E. coli |
|
|
|
|
|
| Topoisomerase IV, Pseudomonas aeruginosa |
|
|
|
|
|
| Topoisomerase IV, Staphylococcus aureus |
|
|
|
|
|
| Topoisomerase IV, Streptococcus pneumoniae |
|
|
|
|
|
| Topoisomerase IV-IN-3 |
|
|
|
|
|
| Topoisomerase ll/ME-1-IN-1 |
|
|
|
|
|
| Topoisomerases/ribosomes-IN-1 |
|
|
|
|
|
| Topotecan acetate |
|
|
|
|
|
| Topotecan hydrochloride hydrate |
|
|
|
|
|
| Topotecan-d5 |
|
|
|
|
|
| Topovale |
|
|
|
|
99.94% |
| TP0480066 |
|
|
|
|
|
| TP3011 |
|
|
|
|
|
| Type II topoisomerase inhibitor 1 |
|
|
|
|
|
| Tyrphostin AG213 |
|
|
|
|
|
| Val-Ala-PABC-Exatecan |
|
|
|
|
99.90% |
| Val-Ala-PABC-Exatecan trifluoroacetate |
|
|
|
|
98.39% |
| Val-Cit-Exatecan |
|
|
|
|
|
| Val-Cit-PAB-Exatecan |
|
|
|
|
99.79% |
| Val-Cit-PAB-Exatecan TFA |
|
|
|
|
99.73% |
| Val-Cit-PABC-DOX |
|
|
|
|
|
| VcMMAE-Deruxtecan |
|
|
|
|
98.01% |
| Viquidacin |
|
|
|
|
|
| Voreloxin |
|
|
|
|
99.85% |
| Voreloxin Hydrochloride |
|
|
|
|
99.73% |
| WJ35435 |
|
|
|
|
|
| XK469 |
|
|
|
|
98% |
| XK469 sodium |
|
|
|
|
|
| XR11576 |
|
|
|
|
|
| XSJ05 |
|
|
|
|
|
| XSJ110 |
|
|
|
|
|
| XSJ151 |
|
|
|
|
|
| XSJ81 |
|
|
|
|
|
| YCJ-02 |
|
|
|
|
|
| Zabofloxacin |
|
|
|
|
|
| Zabofloxacin hydrochloride |
|
|
|
|
99.54% |
| ZLHQ-5f |
|
|
|
|
|
| ZM484 |
|
|
|
|
|
| Zorubicin |
|
|
|
|
|
| ZW-251 |
|
|
|
|
|
| β-Glu-PAB(CH2NH2)-Exatecan |
|
|
|
|
96.60% |
| β-Lapachone |
|
|
|
|
99.93% |
| Ciprofloxacin lactate |
|
|
|
|
|
| Alternariol |
|
|
|
|
99.79% |
| Alternariol-d2 |
|
|
|
|
|
| Irinotecan-d10 |
|
|
|
|
98.02% |
| Irinotecan-d10 hydrochloride |
|
|
|
|
99.76% |
| Irinotecan-13C6 |
|
|
|
|
|
| Irinotecan |
|
|
|
|
99.97% |
| (S)-10-Hydroxycamptothecin |
|
|
|
|
99.74% |
| Irinotecan hydrochloride |
|
|
|
|
99.89% |
| Irinotecan-d5 hydrochloride |
|
|
|
|
|
| Exatecan-d3 mesylate |
|
|
|
|
|
| Exatecan |
|
|
|
|
99.78% |
| Exatecan Intermediate 1 |
|
|
|
|
100.1% |
| Exatecan Intermediate 1-d5 |
|
|
|
|
99.90% |
| Exatecan-d5 mesylate |
|
|
|
|
99.83% |
| Exatecan mesylate |
|
|
|
|
101.1% |
| Exatecan mesylate dihydrate |
|
|
|
|
|
| Etoposide-13C,d3 |
|
|
|
|
|
| Etoposide-d3 |
|
|
|
|
|
| Etoposide-d4 |
|
|
|
|
|
| Etoposide |
|
|
|
|
99.93% |
| Corydamine |
|
|
|
|
|
| Gatifloxacin |
|
|
|
|
99.69% |
| Gatifloxacin-d4 |
|
|
|
|
|
| Gatifloxacin hydrochloride |
|
|
|
|
99.76% |
| Gatifloxacin-d3 hydrochloride |
|
|
|
|
|
| Gatifloxacin-d4 hydrochloride |
|
|
|
|
|
| Garenoxacin |
|
|
|
|
98.62% |
| Garenoxacin Mesylate hydrate |
|
|
|
|
99.95% |
| Pixantrone free base |
|
|
|
|
|
| Pixantrone hydrochloride |
|
|
|
|
|
| Gimatecan |
|
|
|
|
99.28% |
| Pirarubicin |
|
|
|
|
99.14% |
| Camptothecin |
|
|
|
|
99.77% |
| Camptothecin-d5 |
|
|
|
|
99.61% |
| Pefloxacin |
|
|
|
|
99.37% |
| Pefloxacin-d3 |
|
|
|
|
99.35% |
| Pefloxacin-d5 |
|
|
|
|
98.33% |
| Amsacrine |
|
|
|
|
99.91% |
| Levofloxacin-d3 hydrochloride |
|
|
|
|
|
| Levofloxacin-d3 sodium |
|
|
|
|
|
| Levofloxacin |
|
|
|
|
99.92% |
| Levofloxacin hydrate |
|
|
|
|
99.98% |
| Isodiospyrin |
|
|
|
|
99.72% |
| Isosteviol |
|
|
|
|
99.86% |
| Topotecan-d6 |
|
|
|
|
|
| Topotecan |
|
|
|
|
98.04% |
| Topotecan-d6 dihydrochloride |
|
|
|
|
|
| Trovafloxacin |
|
|
|
|
99.43% |
| Trovafloxacin mesylate |
|
|
|
|
99.76% |
| Teniposide |
|
|
|
|
98.40% |
| Daunorubicin-13C,d3 TFA |
|
|
|
|
|
| Daunorubicin |
|
|
|
|
99.94% |
| Daunorubicin citrate |
|
|
|
|
|
| Diospyrin |
|
|
|
|
|
| Groenlandicine |
|
|
|
|
99.72% |
| Bisantrene |
|
|
|
|
98.06% |
| Flumequine-13C3 |
|
|
|
|
|
| Flumequine |
|
|
|
|
99.65% |
| Amrubicin |
|
|
|
|
|
| Amonafide |
|
|
|
|
99.92% |
| Nitidine chloride |
|
|
|
|
99.82% |
| Lomefloxacin |
|
|
|
|
99.99% |
| Hycanthone |
|
|
|
|
99.81% |
| Chrysosplenetin |
|
|
|
|
99.84% |
| Ellipticine |
|
|
|
|
99.59% |
| Ellipticine hydrochloride |
|
|
|
|
99.01% |
| Ciprofloxacin |
|
|
|
|
99.81% |
| Ciprofloxacin-d4 |
|
|
|
|
|
| Ciprofloxacin hydrochloride monohydrate |
|
|
|
|
99.88% |
| Gatifloxacin mesylate |
|
|
|
|
|
| Gemifloxacin mesylate |
|
|
|
|
99.59% |
| Pefloxacin mesylate |
|
|
|
|
99.73% |
| Pefloxacin mesylate dihydrate |
|
|
|
|
98.11% |
| Levofloxacin mesylate |
|
|
|
|
|
| Betulinic acid-d3 |
|
|
|
|
99% |
| Betulinic acid |
|
|
|
|
99.88% |
| Irinotecan hydrochloride trihydrate |
|
|
|
|
99.89% |
| Idarubicin hydrochloride |
|
|
|
|
99.94% |
| Pirarubicin Hydrochloride |
|
|
|
|
99.14% |
| Amsacrine hydrochloride |
|
|
|
|
99.92% |
| Berberine-d6 chloride |
|
|
|
|
|
| Berberine chloride |
|
|
|
|
99.92% |
| Berberine chloride hydrate |
|
|
|
|
99.69% |
| Levofloxacin hydrochloride |
|
|
|
|
99.99% |
| Topotecan hydrochloride |
|
|
|
|
99.79% |
| Daunorubicin hydrochloride |
|
|
|
|
99.67% |
| Amrubicin hydrochloride |
|
|
|
|
98.78% |
| Lomefloxacin hydrochloride |
|
|
|
|
99.97% |
| Ciprofloxacin monohydrochloride |
|
|
|
|
99.90% |
| Mitoxantrone-d8 dihydrochloride |
|
|
|
|
|
| Mitoxantrone dihydrochloride |
|
|
|
|
98.98% |
| Epirubicin hydrochloride |
|
|
|
|
99.62% |
| Belotecan hydrochloride |
|
|
|
|
99.97% |
| Belotecan-d7 hydrochloride |
|
|
|
|
99.90% |
| Besifloxacin Hydrochloride |
|
|
|
|
98.49% |
| Aclacinomycin A hydrochloride |
|
|
|
|
|
| Doxorubicin hydrochloride |
|
|
|
|
99.90% |
| Berberine hemisulfate |
|
|
|
|
99.63% |
| Etoposide phosphate |
|
|
|
|
99.44% |
| Podocarpusflavone A |
|
|
|
|
99.62% |
| Mitoxantrone-d8 |
|
|
|
|
|
| Mitoxantrone |
|
|
|
|
99.58% |
| Cholesteryl hemisuccinate |
|
|
|
|
99.94% |
| Suramin |
|
|
|
|
|
| Suramin sodium salt |
|
|
|
|
99.98% |
| Intoplicine |
|
|
|
|
98.36% |
| Moxifloxacin hydrochloride monohydrate |
|
|
|
|
98.17% |
| Nalidixic acid sodium salt |
|
|
|
|
99.83% |
| Nalidixic acid |
|
|
|
|
99.97% |
| Nalidixic Acid-d5 |
|
|
|
|
|
| Epirubicin |
|
|
|
|
99.61% |
| Belotecan |
|
|
|
|
99.86% |
| Aurintricarboxylic acid |
|
|
|
|
92.0% |
| Aclacinomycin A |
|
|
|
|
96.22% |
| Artemisitene |
|
|
|
|
99.93% |
| Pixantrone |
|
|
|
|
98.75% |
| Pixantrone-d8 |
|
|
|
|
|
| Berberine |
|
|
|
|
|
| Berberine sulfate |
|
|
|
|
99.23% |